Clinical Focus

• Interventional Cardiology
• Coronary Artery Disease
• Percutaneous aortic valve
• Aortic Stenosis
• Coronary Physiology

Professional Education

Postdoctoral Advisees

Seema Sinha,  Andy Yong

Graduate & Fellowship Program Affiliations

• Medicine

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

Dr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.

Clinical Trials

• A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation Recruiting
• A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation Recruiting
• The use of the TAXUS Liberté stent in conjunction with a medication called prasugrel (Effient). Recruiting
• Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.) No longer recruiting
• ACE Inhibition and Cardiac Allograft Vasculopathy Enrolling by Invitation

Publications

• Functional SYNTAX score for risk assessment in multivessel coronary artery disease. Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, De Bruyne B, Pijls NH, Fearon WF. J Am Coll Cardiol. 2011; 58 (12): 1211-8
• Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Fearon WF, Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, Siebert U. Circulation. 2010; 122 (24): 2545-50
• Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. N Engl J Med. 2009; 360 (3): 213-24
• Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Fearon WF, Fearon DT. Circulation. 2008; 117 (20): 2577-9
• Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC. J Am Coll Cardiol. 2008; 51 (5): 560-5